Furthermore, our discovery of the key role of NR4A2 signalling in Th17 differentiation and our identification of the involvement of NR4A2 in generating autoimmune response in vivo suggest a new target for intervention in Th17-mediated autoimmune disease. The gene discussed is NR4A2; the disease is autoimmune disease.